Carnick & Kubik’s Eli Lilly LLY Stock Holding History

Carnick & Kubik’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$623K	Buy	8,647 +225	+3%	+$17K	0.19%	153
2015 Q4	$710K	Buy	8,422 +235	+3%	+$19.5K	0.46%	72
2015 Q3	$685K	Buy	8,187 +175	+2%	+$14.8K	0.48%	73
2015 Q2	$669K	Hold	8,012	–	–	0.55%	68
2015 Q1	$582K	Buy	8,012 +75	+0.9%	+$5.34K	0.49%	85
2014 Q4	$548K	Buy	7,937 +575	+8%	+$38.8K	0.47%	87
2014 Q3	$477K	Sell	7,362 -500	-6%	-$31.7K	0.44%	88
2014 Q2	$489K	Sell	7,862 -675	-8%	-$40.3K	0.49%	77
2014 Q1	$502K	Hold	8,537	–	–	0.48%	72
2013 Q4	$435K	Buy	8,537 +525	+7%	+$26.3K	0.39%	97
2013 Q3	$403K	Sell	8,012 -90	-1%	-$4.71K	0.62%	74
2013 Q2	$398K	Buy	+8,102	New	+$441K	0.49%	84

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Carnick & Kubik's LLY Position: Q1 2016 in Review

Carnick & Kubik increased its Eli Lilly (LLY) stake by 2.7% in Q1 2016, buying an estimated $17K and bringing the position to 8,647 shares worth $623K. The position accounts for 0.19% of the portfolio, ranked #153.

Carnick & Kubik first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $710K in Q4 2015. 1,151 funds tracked by Wall St. Rank hold LLY as of Q1 2016.

Carnick & Kubik held 8,647 shares of Eli Lilly worth $623K as of Q1 2016.
Carnick & Kubik bought 225 Eli Lilly shares in Q1 2016, an estimated $17K.
Eli Lilly made up 0.19% of Carnick & Kubik's portfolio in Q1 2016, its #153 holding.
Carnick & Kubik first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
Carnick & Kubik's Eli Lilly position peaked at $710K in Q4 2015.
1,151 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.